Stem cell shot aims to save limbs in rare artery disease
NCT ID NCT05854615
First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This study is testing whether injections of Stempeucel, a stem cell product made from donor bone marrow, can help people with critical limb ischemia caused by Buerger's disease. The goal is to see if it reduces pain, heals ulcers, improves blood flow, and prevents amputation. Only 3 participants will be enrolled, and they will be followed for one year to check safety and effectiveness.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Stempeucel (stem cells from donor bone marrow)
What this could lead to
If it works, this could point toward a treatment that reduces pain, heals ulcers, and lowers amputation risk for people with Buerger's disease.
What could go wrong
This is a very small feasibility study with only 3 participants, so results may not apply broadly. Stem cell treatments can have side effects like infection or immune reactions.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CRITICAL LIMB ISCHEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hospital Canselor Tunku Mukhriz
RECRUITINGKuala Lumpur, 56000, Malaysia
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Contact